|In vivo imaging of amyloid deposition in Alzheimer disease using the radioligand 18F-AV-45 (flobetapir F 18)|
DF Wong, PB Rosenberg, Y Zhou, A Kumar, V Raymont, HT Ravert, ...
Journal of nuclear medicine 51 (6), 913-920, 2010
|Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease|
M Thambisetty, A Simmons, L Velayudhan, A Hye, J Campbell, Y Zhang, ...
Archives of general psychiatry 67 (7), 739-748, 2010
|Self-reported sleep and β-amyloid deposition in community-dwelling older adults|
AP Spira, AA Gamaldo, Y An, MN Wu, EM Simonsick, M Bilgel, Y Zhou, ...
JAMA neurology 70 (12), 1537-1543, 2013
|Sex differences in striatal dopamine release in healthy adults|
CA Munro, ME McCaul, DF Wong, LM Oswald, Y Zhou, J Brasic, ...
Biological psychiatry 59 (10), 966-974, 2006
|Association between midlife vascular risk factors and estimated brain amyloid deposition|
RF Gottesman, ALC Schneider, Y Zhou, J Coresh, E Green, N Gupta, ...
Jama 317 (14), 1443-1450, 2017
|Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving|
DF Wong, H Kuwabara, DJ Schretlen, KR Bonson, Y Zhou, A Nandi, ...
Neuropsychopharmacology 31 (12), 2716-2727, 2006
|Relationships among ventral striatal dopamine release, cortisol secretion, and subjective responses to amphetamine|
LM Oswald, DF Wong, M McCaul, Y Zhou, H Kuwabara, L Choi, J Brasic, ...
Neuropsychopharmacology 30 (4), 821-832, 2005
|Elevated intrasynaptic dopamine release in Tourette’s syndrome measured by PET|
HS Singer, S Szymanski, J Giuliano, F Yokoi, AS Dogan, JR Brasic, ...
American Journal of Psychiatry 159 (8), 1329-1336, 2002
|Longitudinal cognitive decline is associated with fibrillar amyloid-beta measured by [11C] PiB|
SM Resnick, J Sojkova, Y Zhou, Y An, W Ye, DP Holt, RF Dannals, ...
Neurology 74 (10), 807-815, 2010
|Mechanisms of dopaminergic and serotonergic neurotransmission in Tourette syndrome: clues from an in vivo neurochemistry study with PET|
DF Wong, JR Brašić, HS Singer, DJ Schretlen, H Kuwabara, Y Zhou, ...
Neuropsychopharmacology 33 (6), 1239-1251, 2008
|Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates|
TR Guilarte, MK Chen, JL McGlothan, T Verina, DF Wong, Y Zhou, ...
Experimental neurology 202 (2), 381-390, 2006
|Feature-based image patch approximation for lung tissue classification|
Y Song, W Cai, Y Zhou, DD Feng
IEEE transactions on medical imaging 32 (4), 797-808, 2013
|Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre‐synaptic mechanism (s): implications to manganese‐induced parkinsonism|
TR Guilarte, NC Burton, JL McGlothan, T Verina, Y Zhou, M Alexander, ...
Journal of neurochemistry 107 (5), 1236-1247, 2008
|Association of amphetamine-induced striatal dopamine release and cortisol responses to psychological stress|
GS Wand, LM Oswald, ME McCaul, DF Wong, E Johnson, Y Zhou, ...
Neuropsychopharmacology 32 (11), 2310-2320, 2007
|11C-MCG: Synthesis, Uptake Selectivity, and Primate PET of a Probe for Glutamate Carboxypeptidase II (NAALADase)|
MG Pomper, JL Musachio, J Zhang, U Scheffel, Y Zhou, J Hilton, A Maini, ...
Molecular imaging 1 (2), 15353500200202109, 2002
|Linear regression with spatial constraint to generate parametric images of ligand-receptor dynamic PET studies with a simplified reference tissue model|
Y Zhou, CJ Endres, JR Brašić, SC Huang, DF Wong
Neuroimage 18 (4), 975-989, 2003
|Dynamic whole-body PET parametric imaging: I. Concept, acquisition protocol optimization and clinical application|
NA Karakatsanis, MA Lodge, AK Tahari, Y Zhou, RL Wahl, A Rahmim
Physics in Medicine & Biology 58 (20), 7391, 2013
|Glucose intolerance, insulin resistance, and pathological features of Alzheimer disease in the Baltimore Longitudinal Study of Aging|
M Thambisetty, EJ Metter, A Yang, H Dolan, C Marano, AB Zonderman, ...
JAMA neurology 70 (9), 1167-1172, 2013
|Impulsivity and chronic stress are associated with amphetamine-induced striatal dopamine release|
LM Oswald, DF Wong, Y Zhou, A Kumar, J Brasic, M Alexander, W Ye, ...
Neuroimage 36 (1), 153-166, 2007
|VMAT2 and dopamine neuron loss in a primate model of Parkinson’s disease|
MK Chen, H Kuwabara, Y Zhou, RJ Adams, JR Brašić, JL McGlothan, ...
Journal of neurochemistry 105 (1), 78-90, 2008